CreditReports.dk
HomeScreen companies

Sapphire Bioscience Holding ApS Financials, key figures and credit report

CVR number: 38599917 Established 2017 Industry: 64 Financial service activities, except insurance and pension funding
Company contact details
Industriparken 39, 2750 Ballerup
Gross profit 126 526.0 kDKK FY 2025 -13.9% vs 2024
EBIT 7 958.0 kDKK FY 2025 -84.3% vs 2024
Net debt 25 320.0 kDKK FY 2025 +161.9% vs 2024
Quick ratio 0.8 FY 2025 -2.1 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit108 874.00136 234.00132 314.00146 897.00126 526.00
Employee benefit expenses-44 010.00-56 002.00-73 737.00-84 375.00- 103.92
Total depreciation-16 746.00-22 628.00-17 535.00-11 806.00-14 650.00
EBIT48 118.0057 604.0041 042.0050 716.007 958.00
Other financial income3 057.004 947.005 558.001 445.00
Other financial expenses- 925.00-1 109.00-6 633.00-2 991.00-4 579.00
Pre-tax profit47 193.0059 552.0039 356.0053 283.004 824.00
Income taxes-9 253.00-12 868.00-10 892.00-10 263.00-1 558.00
Net earnings37 940.0046 684.0028 464.0043 020.003 266.00

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure47 450.0041 316.0044 742.0074 324.00111 789.00
Intangible rights401.00771.00570.00363.00154.00
Intangible assets total47 851.0042 087.0045 312.0074 687.00111 943.00
Land and waters24 011.0024 090.003 936.003 378.00
Buildings3 076.003 303.006 659.0011 074.009 435.00
Machinery and equipment4 959.002 212.001 595.002 046.002 182.00
Tangible assets total32 046.0029 605.008 254.0017 056.0014 995.00
Other non-current investments809.00922.001 086.001 187.001 450.00
Investments total1 520.002 096.004 671.004 014.004 204.00
Long term receivables total
Semifinished products8 070.006 020.008 892.009 471.0012 229.00
Raw materials and consumables18 516.0027 354.0032 666.0034 201.0034 852.00
Finished products/goods15 710.0027 952.0028 931.0021 593.0027 797.00
Advance payments214.00
Inventories total42 510.0061 326.0070 489.0065 265.0074 878.00
Current trade debtors20 397.0043 894.0043 599.0043 068.0036 131.00
Prepayments and accrued income1 597.003 586.003 346.002 609.003 974.00
Current other receivables2 509.001 873.001 930.002 660.00169.00
Current deferred tax assets2 963.00172.001 025.001 678.00
Short term receivables total27 466.0049 525.0049 900.0048 337.0041 952.00
Cash and bank deposits48 360.0049 244.0043 983.0045 033.009 209.00
Cash and cash equivalents48 360.0049 244.0043 983.0045 033.009 209.00
Balance sheet total (assets)199 753.00233 883.00222 609.00254 392.00257 181.00

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital15 878.0015 878.0015 878.0015 878.0015 878.00
Shares repurchased31 755.00
Other reserves25 488.0029 251.0035 775.0057 972.0087 195.00
Retained earnings58 076.0060 666.0069 959.0063 845.0041 938.00
Profit of the financial year37 940.0046 684.0028 464.0043 020.003 266.00
Shareholders equity total137 382.00184 234.00150 076.00180 715.00148 277.00
Provisions624.005 652.0010 053.0017 293.0017 698.00
Non-current loans from credit institutions463.00263.0088.003 708.002 512.00
Non-current liabilities total463.00263.0088.003 708.002 512.00
Current loans from credit institutions15 445.001 423.00400.00800.00
Advances received21 047.0020 772.0034 248.0020 345.0021 896.00
Current trade creditors13 742.0011 458.0010 892.0019 206.0011 516.00
Current owed to group member31 217.00
Short-term deferred tax liabilities2 716.00225.002 023.001 537.00120.00
Other non-interest bearing current liabilities8 334.009 856.0015 229.0011 188.0023 145.00
Current liabilities total61 284.0043 734.0062 392.0052 676.0088 694.00
Balance sheet total (liabilities)199 753.00233 883.00222 609.00254 392.00257 181.00
Page generated